IL31139A - Treatment of red blood cells - Google Patents

Treatment of red blood cells

Info

Publication number: IL31139A
Authority: IL; Israel
Prior art keywords: blood cells; red blood; microwave energy; blood; zone
Prior art date: 1967-12-01

Application number

IL31139A

Other languages

English (en)

Hebrew (he)

Other versions

IL31139A0 (en

Original Assignee

Gray Ind Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1967-12-01

Filing date

1968-11-22

Publication date

1972-05-30

1968-11-22 Application filed by Gray Ind Inc filed Critical Gray Ind Inc

1969-01-29 Publication of IL31139A0 publication Critical patent/IL31139A0/xx

1972-05-30 Publication of IL31139A publication Critical patent/IL31139A/en

Links

210000003743 erythrocyte Anatomy 0.000 title claims description 42
238000000034 method Methods 0.000 claims description 21
210000004027 cell Anatomy 0.000 claims description 17
239000002826 coolant Substances 0.000 claims description 15
230000000877 morphologic effect Effects 0.000 claims description 6
230000037361 pathway Effects 0.000 claims description 3
210000004369 blood Anatomy 0.000 description 51
239000008280 blood Substances 0.000 description 51
239000007789 gas Substances 0.000 description 22
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 13
239000000523 sample Substances 0.000 description 11
230000002939 deleterious effect Effects 0.000 description 8
230000004660 morphological change Effects 0.000 description 8
239000004033 plastic Substances 0.000 description 8
229920003023 plastic Polymers 0.000 description 8
206010018910 Haemolysis Diseases 0.000 description 6
206010035551 Pleocytosis Diseases 0.000 description 6
229910001873 dinitrogen Inorganic materials 0.000 description 6
230000008588 hemolysis Effects 0.000 description 6
206010024378 leukocytosis Diseases 0.000 description 6
239000003146 anticoagulant agent Substances 0.000 description 5
229940127219 anticoagulant drug Drugs 0.000 description 5
239000011521 glass Substances 0.000 description 5
230000008569 process Effects 0.000 description 5
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
229910002092 carbon dioxide Inorganic materials 0.000 description 3
230000002045 lasting effect Effects 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
102000003929 Transaminases Human genes 0.000 description 2
108090000340 Transaminases Proteins 0.000 description 2
PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
238000012742 biochemical analysis Methods 0.000 description 2
210000000601 blood cell Anatomy 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
239000001569 carbon dioxide Substances 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
150000001805 chlorine compounds Chemical class 0.000 description 2
238000001816 cooling Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000000463 material Substances 0.000 description 2
239000012528 membrane Substances 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
238000005057 refrigeration Methods 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000011734 sodium Substances 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
101000916532 Rattus norvegicus Zinc finger and BTB domain-containing protein 38 Proteins 0.000 description 1
229910000831 Steel Inorganic materials 0.000 description 1
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
229910052786 argon Inorganic materials 0.000 description 1
230000008901 benefit Effects 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
230000036770 blood supply Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
239000013068 control sample Substances 0.000 description 1
230000001186 cumulative effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
239000008103 glucose Substances 0.000 description 1
239000001307 helium Substances 0.000 description 1
229910052734 helium Inorganic materials 0.000 description 1
SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
229910052743 krypton Inorganic materials 0.000 description 1
DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 1
239000000203 mixture Substances 0.000 description 1
229910052754 neon Inorganic materials 0.000 description 1
GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
239000005022 packaging material Substances 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
239000012466 permeate Substances 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
-1 polyethylene Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
239000004926 polymethyl methacrylate Substances 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000007789 sealing Methods 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
239000010959 steel Substances 0.000 description 1
229940116269 uric acid Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Anesthesiology (AREA)
Cardiology (AREA)
Hematology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

IL31139A 1967-12-01 1968-11-22 Treatment of red blood cells IL31139A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US68712267A	1967-12-01	1967-12-01

Publications (2)

Publication Number	Publication Date
IL31139A0 IL31139A0 (en)	1969-01-29
IL31139A true IL31139A (en)	1972-05-30

Family

ID=24759151

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL31139A IL31139A (en)	1967-12-01	1968-11-22	Treatment of red blood cells

Country Status (11)

Country	Link
US (1)	US3439510A (da)
AT (1)	AT279047B (da)
BE (1)	BE724480A (da)
BR (1)	BR6804416D0 (da)
DE (1)	DE1810890A1 (da)
DK (1)	DK122432B (da)
FR (1)	FR1601131A (da)
GB (1)	GB1224198A (da)
IL (1)	IL31139A (da)
NL (1)	NL6817164A (da)
TR (1)	TR16798A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3926556A (en) *	1973-05-30	1975-12-16	Raymond Marcel Gut Boucher	Biocidal electromagnetic synergistic process
US4059967A (en) *	1976-02-19	1977-11-29	The Community Blood Council Of Greater New York, Inc.	Process for freezing blood platelets
US4250139A (en) *	1979-02-01	1981-02-10	Collagen Corporation	Microwave sterilization of dry protein
FR2569110B1 (fr) *	1984-08-17	1987-09-25	Ionescu Pantelimon Dumitru	Sang animal et moelle osseuse animale decancerisants, transfusibles aux hommes, procede et appareil pour leur preparation
US4975246A (en) *	1985-09-30	1990-12-04	Charm Stanley E	High temperature, short time heating system and method of heating heat-sensitive material
US4839142A (en) *	1985-09-30	1989-06-13	Charm Stanley E	High temperature, short time heating system and method of sterilizing or pasteurizing heat sensitive biological fluids
GB8807380D0 (en) *	1988-03-29	1988-05-05	Gunn A	Blood processing apparatus
JPH0812136B2 (ja) *	1989-12-30	1996-02-07	工業技術院長	凍結方法および装置
ES1055823Y (es) *	2003-10-27	2004-05-01	Salido Yolanda Chia	Biberon esteril.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2169081A (en) *	1937-03-20	1939-08-08	Westinghouse Electric & Mfg Co	Process for the treatment of meat and the product thereof
US2315285A (en) *	1940-01-26	1943-03-30	Westinghouse Electric & Mfg Co	Food treatment and/or storage apparatus
US2480954A (en) *	1944-05-06	1949-09-06	Westinghouse Electric Corp	Dehydration of foods by sublimation
US3070976A (en) *	1959-12-29	1963-01-01	Guhl August	Room air conditioning apparatus

1967
- 1967-12-01 US US687122A patent/US3439510A/en not_active Expired - Lifetime
1968
- 1968-11-22 IL IL31139A patent/IL31139A/en unknown
- 1968-11-26 GB GB56136/68A patent/GB1224198A/en not_active Expired
- 1968-11-26 DE DE19681810890 patent/DE1810890A1/de active Pending
- 1968-11-27 FR FR1601131D patent/FR1601131A/fr not_active Expired
- 1968-11-27 BE BE724480D patent/BE724480A/xx unknown
- 1968-11-29 AT AT1165468A patent/AT279047B/de not_active IP Right Cessation
- 1968-11-29 DK DK584768AA patent/DK122432B/da unknown
- 1968-11-29 NL NL6817164A patent/NL6817164A/xx unknown
- 1968-11-29 BR BR204416/68A patent/BR6804416D0/pt unknown
- 1968-12-02 TR TR16798A patent/TR16798A/xx unknown

Also Published As

Publication number	Publication date
DE1810890A1 (de)	1969-07-10
NL6817164A (da)	1969-06-03
BR6804416D0 (pt)	1973-02-13
FR1601131A (da)	1970-08-10
AT279047B (de)	1970-02-25
TR16798A (tr)	1973-05-01
BE724480A (da)	1969-05-27
GB1224198A (en)	1971-03-03
DK122432B (da)	1972-03-06
US3439510A (en)	1969-04-22
IL31139A0 (en)	1969-01-29

Publication	Publication Date	Title
Ham et al.	1948	Studies on the destruction of red blood cells. iv: thermal injury: action of heat in causing increased spheroidicity, osmotic and mechanical fragilities and hemolysis of erythrocytes; observations on the mechanisms of destruction of such erythrocytes in dogs and in a patient with a fatal thermal burn
US5362442A (en)	1994-11-08	Method for sterilizing products with gamma radiation
US3439510A (en)	1969-04-22	Treatment of red blood cells
Almlid et al.	1988	Effects of glycerol concentration, equilibration time and temperature of glycerol addition on post-thaw viability of boar spermatozoa frozen in straws
US3257072A (en)	1966-06-21	Whole blood storage structure
CA2693293A1 (en)	1996-06-13	Method and bag set for concentrating white cells
JP2008508920A5 (da)	2008-08-28
DE1901751A1 (de)	1969-11-27	Verpackung aus Kunststoffolie fuer extrem tiefe Temperatur
IL46257A (en)	1977-05-31	Process for the preservation of ram semen by freezing
CN1685210A (zh)	2005-10-19	为组织学和病理学检验制备组织样品的方法和系统
Moll et al.	1966	The diffusion coefficient of haemoglobin
Sasaki	1977	Measurement of tritiated thymidine labeling index by incubation in vitro of surgically removed cervical cancer
US3645849A (en)	1972-02-29	Stability of enzymes
Flosdorf et al.	1945	Drying by sublimation
US3660234A (en)	1972-05-02	Method of attenuating viruses
Login et al.	1993	A review of rapid microwave fixation technology: its expanding niche in morphologic studies
IE902301A1 (en)	1991-07-03	Identification Process And Related Method For Use In¹Preparing A Biological Sample
Corsetti et al.	1987	Comparison of quantitative acid-elution technique and flow cytometry for detecting fetomaternal hemorrhage
CN210929356U (zh)	2020-07-07	一种封闭式卵巢组织冷冻装置
Vodovotz et al.	2000	Reduced hematopoietic function and enhanced radiosensitivity of transforming growth factor‐β1 transgenic mice
SU1124974A1 (ru)	1984-11-23	Способ хранени крови
Hershey et al.	1958	Electron-Irradiated and Freeze-Dried Arterial Homografts: Experiences at the St. Louis City Hospital Artery Bank
RU2138162C1 (ru)	1999-09-27	Способ криоконсервации богатой тромбоцитами плазмы
JPS6354681B2 (da)	1988-10-28
SU912169A1 (ru)	1982-03-15	Способ определени сохранности жизнеспособности длительно хранившейс крови